Hikma Pharmaceuticals Plc (HKMPF)
18.10
0.00 (0.00%)
USD |
OTCM |
Apr 29, 16:00
Hikma Pharmaceuticals Market Cap : 3.928B for April 29, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Silence Therapeutics Plc | 334.42M |
| Adaptimmune Therapeutics Plc | 0.0265M |
| Biodexa Pharmaceuticals Plc | 2.146M |
| Oxford Biomedica Plc | 1.028B |
| NuCana Plc | 8.490M |
Market Cap Related Metrics
| PE Ratio | 9.972 |
| PS Ratio | 1.196 |
| PEG Ratio | 0.0887 |
| Price to Free Cash Flow | 95.36 |
| Price | 18.10 |
| Earnings Yield | 10.03% |
| PEGY Ratio | 0.0852 |
| Operating PE Ratio | 7.051 |
| Normalized PE Ratio | 10.79 |